Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Tangible Net Worth Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Tangible Net Worth Ratio of 92.4% as of March 2026. This metric is calculated by deducting intangible assets (€3.18 Billion) from net assets (€41.89 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See GU5 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Tangible Net Worth Ratio (2013–2025)
This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 92.4%, reflecting net assets of €41.89 Billion with intangible assets of €3.18 Billion EUR. See Guangzhou Baiyunshan Pharmaceutical Hold defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see GU5 market cap overview.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.1% | €40.08 Billion | €3.19 Billion | €84.51 Billion | ▲ +0.5 pp |
| 2024 | 91.5% | €37.77 Billion | €3.20 Billion | €81.68 Billion | ▲ +0.2 pp |
| 2023 | 91.3% | €36.68 Billion | €3.20 Billion | €78.59 Billion | ▼ -0.3 pp |
| 2022 | 91.6% | €33.64 Billion | €2.83 Billion | €74.67 Billion | ▼ -0.1 pp |
| 2021 | 91.7% | €31.33 Billion | €2.59 Billion | €66.12 Billion | ▲ +0.4 pp |
| 2020 | 91.3% | €28.21 Billion | €2.45 Billion | €59.76 Billion | ▲ +0.9 pp |
| 2019 | 90.4% | €25.99 Billion | €2.49 Billion | €56.89 Billion | ▼ -5.2 pp |
| 2018 | 95.6% | €23.14 Billion | €1.01 Billion | €51.48 Billion | ▼ -0.6 pp |
| 2017 | 96.2% | €19.26 Billion | €728.81 Million | €28.31 Billion | ▲ +0.0 pp |
| 2016 | 96.2% | €17.65 Billion | €671.32 Million | €25.90 Billion | ▲ +2.4 pp |
| 2015 | 93.8% | €8.68 Billion | €540.17 Million | €15.87 Billion | ▼ -1.2 pp |
| 2014 | 95.0% | €7.92 Billion | €395.20 Million | €14.27 Billion | ▲ +0.3 pp |
| 2013 | 94.7% | €7.02 Billion | €368.86 Million | €12.25 Billion | — |